The American Journal of Medicine
Volume 121, Issue 11 , Pages 960-962 , November 2008

A Hole in the Roof

  • Sandeep Chauhan, MD

      Affiliations

    • Department of General Medicine, Government Medical College and Hospital, Chandigarh, India
    • Corresponding Author InformationRequests for reprints should be addressed to S. Chauhan, MD, Department of General Medicine, Sector 32, Government Medical College and Hospital, Sector 32, Chandigarh, India, 160030
    • ,
  • Yee Chiu, MD, PhD

      Affiliations

    • Inflammation Research Unit, School of Clinical Sciences, Liverpool, United Kingdom
    • ,
  • Andrew Swift, MD

      Affiliations

    • Department of Otorhinolaryngology/Head and Neck Surgery, University Hospital Aintree, University of Liverpool, Liverpool, United Kingdom
    • ,
  • Karolina Griffiths

      Affiliations

    • University of Liverpool School of Medical Education, Liverpool, United Kingdom
    • ,
  • Robert J. Moots, MD, PhD

      Affiliations

    • Inflammation Research Unit, School of Clinical Sciences, Liverpool, United Kingdom

References 

  1. Klinger H. Borderline variants of periarteritis nodosa. Frankf Z Pathol. 1931;42:455–480
  2. Wegener F. About generalised septic vascular diseases. Verh Deut Pathol Ges. 1936;29:202–210
  3. Wegener F. About a peculiar rhinogenic granulomatosis with marked involvement of the arterial system and kidneys. Beitr Pathol Anat. 1939;102:30–68
  4. Stone JH for the Wegener's Granulomatosis Etanercept Trial Research Group. Limited versus severe Wegener's granulomatosis: baseline data on patients in the Wegener's granulomatosis etanercept trial. Arthritis Rheum. 2003;48:2299–2309
  5. Mohammad AJ, Jacobsson LT, Mahr AD, et al. Prevalence of Wegener's granulomatosis, microscopic polyangiitis, polyarteritis nodosa and Churg-Strauss syndrome withi a defined population in southern Sweden. Rheumatology (Oxford). 2007;46:1329–1337
  6. Reinhold-Keller E, Herlyn K, Wagner-Bastmeyer R, Gross WL. Stable incidence of primary systemic vasculitides over five years: results from the German vasculitis register. Arthritis Rheum. 2005;53:93–99
  7. Cotch MF, Hoffman GS, Yerg DE, et al. epidemiology of Wegener's granulomatosis (Estimates of the five-year period prevalence, annual mortality, and geographic disease distribution from population-based data sources). Arthritis Rheum. 1996;39:87–92
  8. Hoffman GS, Kerr GS, Leavitt RY, et al. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med. 1992;116:488–498
  9. Reinhold-Keller E, Beuge N, Latza U, et al. An interdisciplinary approach to the care of patients with Wegener's granulomatosis: long-term outcome in 155 patients. Arthritis Rheum. 2000;43:1021–1032
  10. Simsek S, de Vries XH, Jol JA, et al. Sino-nasal bony and cartilaginous destruction associated with cocaine abuse, S. aureus, and antineutrophil cytoplasmic antibodies. Neth J Med. 2006;64:248–251
  11. Savige J, Davies D, Falk RJ, et al. Antineutrophil cytoplasmic antibodies and associated diseases: a review of the clinical and laboratory features. Kidney Int. 2000;57:846–862
  12. Bosch X, Guilabert A, Font J. Antineutrophil cytoplasmic antibodies. Lancet. 2006;368:404–418
  13. Yazici Y. Vasculitis update, 2007. Bull NYU Hosp Jt Dis. 2007;65:212–214
  14. Devaney KO, Travis WD, Hoffman G, et al. Interpretation of head and neck biopsies in Wegener's granulomatosis (A pathologic study of 126 biopsies in 70 patients). Am J Surg Pathol. 1990;14:555–564
  15. Blanksma CJ, Brand HS. Cocaine abuse: orofacial manifestations and implications for dental treatment. Int Dent J. 2005;55:365–369
  16. Barrak HA. Hard palate perforation due to mucormycosis: report of 4 cases. J Laryngol Otol. 2007;121:1099–1102
  17. Vargas-Aguayo AM, López-Pérez VM. Centrofacial lymphoma, cause of middle line granuloma syndrome (Report of a case). Gac Med Mex. 1998;134:743–746
  18. Lavalle C, Gudiño J, Reinoso SR, et al. Behçet's syndrome and palate perforation. Arthritis Rheum. 1979;22:308
  19. Lamprecht P, Till A, Steinmann J, et al. Current state of biologicals in the management of systemic vasculitis. Ann N Y Acad Sci. 2007;1110:261–270

 Parwathi “Uma” Paniker, MD, Section Editor

 All authors declare that this article did not require any funding and we all were involved with the case and participated in design and writing of the manuscript which also included the key words and had acess to all the data. There are also no conflicts of interests.

PII: S0002-9343(08)00752-3

doi: 10.1016/j.amjmed.2008.07.014

The American Journal of Medicine
Volume 121, Issue 11 , Pages 960-962 , November 2008

Article Tools

* Image Usage & Resolution